VCM
RETA

Versant Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Versant Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$510 – 2102
2023
Q2 		$510 Buy
+5
New +$510 ﹤0.01% 1829